Gulf Medical University Ajman UAE, Ajman, UAE.
Pharmacy, Response Plus medical, Abu Dhabi, UAE.
Eur J Hosp Pharm. 2022 Jan;29(1):2-7. doi: 10.1136/ejhpharm-2021-002914. Epub 2021 Nov 30.
This meta-analysis aims to evaluate inappropriate antibiotic prescribing in the Gulf region and determine the effect of pharmacist-led antimicrobial stewardship (AMS) programmes on reducing inappropriateness.
Articles were searched, analysed, and quality assessed through the risk of bias (ROB) quality assessment tool to select articles with a low level of bias. In step 1, 515 articles were searched, in step 2, 2360 articles were searched, and ultimately 32 articles were included by critical analysis. Statistical analysis used to determine risk ratio and standard mean differences were calculated using Review manager 5.4; 95% confidence intervals were calculated using the fixed-effect model. The I statistic assessed heterogeneity. In statistical heterogeneity, subgroup and sensitivity analyses, a random effect model was performed. The α threshold was 0.05. The primary outcome was inappropriateness in antibiotic prescribing in the Gulf region and reduction of inappropriateness through AMS.
Detailed review and analysis of 18 studies of inappropriate antibiotic prescribing in the Gulf region showed the risk of inappropriateness was 43 669/100 846=43.3% (pooled RR 1.31, 95% CI 1.30 to 1.32). Test with overall effect was 58.87; in the second step 28 AMS programmes led by pharmacists showed reduced inappropriateness in AMS with pharmacist versus pre-AMS without pharmacist (RR 0.36, 95% CI 0.32 to 0.39).
Inappropriate antibiotic prescribing in the Gulf region is alarming and needs to be addressed through pharmacist-led AMS programmes.
本荟萃分析旨在评估海湾地区抗生素处方的不当情况,并确定药剂师主导的抗菌药物管理(AMS)方案对减少不适当处方的影响。
通过偏倚风险(ROB)质量评估工具搜索、分析和评估文章,以选择偏倚程度低的文章。在步骤 1 中搜索了 515 篇文章,在步骤 2 中搜索了 2360 篇文章,最终通过批判性分析纳入了 32 篇文章。使用 Review Manager 5.4 计算风险比和标准均数差,使用固定效应模型计算 95%置信区间。使用 I 统计量评估异质性。在存在统计学异质性的情况下,进行亚组和敏感性分析,使用随机效应模型。α 阈值为 0.05。主要结局是海湾地区抗生素处方的不适当性以及 AMS 降低不适当性。
对海湾地区 18 项抗生素处方不适当性研究的详细审查和分析表明,不适当性的风险为 43 669/100 846=43.3%(合并 RR 1.31,95%CI 1.30 至 1.32)。总体效果检验为 58.87;在第二步中,28 项由药剂师主导的 AMS 方案显示,与 AMS 前无药剂师相比,药剂师主导的 AMS 降低了不适当性(RR 0.36,95%CI 0.32 至 0.39)。
海湾地区抗生素处方的不适当性令人震惊,需要通过药剂师主导的 AMS 方案加以解决。